Technical Analysis for ANIP - ANI Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
D 55.10 -1.06% -0.59
ANIP closed down 1.06 percent on Wednesday, November 20, 2024, on 1.27 times normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down

Date Alert Name Type % Chg
Slingshot Bearish Bearish Swing Setup 0.00%
NR7 Range Contraction 0.00%
Oversold Stochastic Weakness 0.00%
Lower Bollinger Band Walk Weakness -1.06%
Stochastic Reached Oversold Weakness -1.06%
Gapped Down Weakness -1.06%
Lower Bollinger Band Touch Weakness -1.06%
Oversold Stochastic Weakness -1.06%
MACD Bearish Centerline Cross Bearish -0.27%
Below Lower BB Weakness -0.27%

   Recent Intraday Alerts

Alert Time
Rose Above Previous Day's High about 20 hours ago
Fell Below Lower Bollinger Band about 22 hours ago
Down 2 % about 22 hours ago
Down 1% about 22 hours ago
Lower Bollinger Band Support about 22 hours ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

ANI Pharmaceuticals, Inc. Description

ANI Pharmaceuticals, Inc. develops, manufactures, and markets prescription and over-the-counter pharmaceuticals. It offers liquid, powder, oral solid dose, and cough/cold products; and antacids, laxatives, and other stomach remedies. The company also provides hydrocortisone retention enema, esterified estrogen and methyltestosterone, fluvoxamine maleate tablets, hydrocortisone rectal suspension, metoclopramide oral solution, opium tincture, and metoclopramide tablets. In addition, ANI Pharmaceuticals offers contract manufacturing services for other pharmaceutical companies. It offers its products through wholesalers, smaller regional distributors and chains, and pharmacy and retail outlets in the United States. ANI Pharmaceuticals, Inc. was formerly known as ASHCO. The company was founded in 2001 and is based in Baudette, Minnesota. It has manufacturing facilities in Gulfport, Mississippi; and Baudette, Minnesota. ANI Pharmaceuticals, Inc. is a former subsidiary of Bactolac Pharmaceutical Inc.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Pharmaceutical Acid Retail Outlets Pharmacology Suspension Manufacturing Facilities Contract Manufacturing Chloroarenes Contract Manufacturing Services Cough Estrogen Testosterone Antacid Antiemetics Laxatives Enema Metoclopramide Offers Contract Manufacturing Services Prolactin Releasers

Is ANIP a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 70.81
52 Week Low 48.2
Average Volume 287,994
200-Day Moving Average 62.17
50-Day Moving Average 58.35
20-Day Moving Average 58.21
10-Day Moving Average 58.39
Average True Range 2.28
RSI (14) 39.02
ADX 14.16
+DI 16.34
-DI 25.37
Chandelier Exit (Long, 3 ATRs) 56.39
Chandelier Exit (Short, 3 ATRs) 60.77
Upper Bollinger Bands 61.95
Lower Bollinger Band 54.47
Percent B (%b) 0.08
BandWidth 12.84
MACD Line -0.60
MACD Signal Line -0.13
MACD Histogram -0.4636
Fundamentals Value
Market Cap 1.13 Billion
Num Shares 20.4 Million
EPS 0.54
Price-to-Earnings (P/E) Ratio 102.04
Price-to-Sales 2.57
Price-to-Book 2.68
PEG Ratio 1.06
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 57.74
Resistance 3 (R3) 57.83 57.03 57.30
Resistance 2 (R2) 57.03 56.36 56.99 57.15
Resistance 1 (R1) 56.07 55.95 55.67 55.98 57.01
Pivot Point 55.27 55.27 55.08 55.23 55.27
Support 1 (S1) 54.31 54.60 53.91 54.22 53.19
Support 2 (S2) 53.51 54.19 53.47 53.05
Support 3 (S3) 52.55 53.51 52.90
Support 4 (S4) 52.46